Introduction Recently introduced robotic assisted neurointervention holds exciting future potential in the treatment of neurovascular diseases.

Aim of Study The aim of this study was to evaluate the application of CorPath GRX robotic platform for coiling, stenting, and flow-diversion treatments of cerebral aneurysms.

Methods This is the largest to date case series from a single physician treating 43 cerebral aneurysm patients using the Corpath GRX Robot (Siemens Healthineers Endovascular Robotics, Newton, Massachusetts, USA) from March 2022 to March 2023.

Results Coiling alone was performed in 4 patients, both coiling and stenting in 8 patients, and 31 patients underwent flow-diversion. Five patients presented with ruptured aneurysms while the rest were unruptured. Internal Carotid Artery was the most common location at 44.2% (19/43) and the mean aneurysm height and neck width were 6.0 ± 2.6 mm and 4.2 ± 2.5 mm respectively. All procedures were performed successfully with no intra-operative complications. Only two conversions to manual technique occurred.

Conclusion This series affirms the feasibility, efficacy and safety of robotic-assisted cerebral aneurysm treatments, and serves as a stepping stone towards the potential future application of building on the current technological platform for achieving the goal of remote thrombectomy.

Disclosure of Interest n/a